RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 140 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $93,000 | -57.3% | 78,462 | +23.2% | 0.01% | -64.0% |
| Q1 2021 | $218,000 | +53.5% | 63,679 | -17.7% | 0.02% | +19.0% |
| Q2 2020 | $142,000 | +84.4% | 77,390 | +161.8% | 0.02% | +61.5% |
| Q2 2019 | $77,000 | -36.4% | 29,562 | -37.1% | 0.01% | -35.0% |
| Q1 2019 | $121,000 | +45.8% | 47,031 | +30.9% | 0.02% | +42.9% |
| Q4 2018 | $83,000 | 0.0% | 35,939 | +39.1% | 0.01% | +16.7% |
| Q3 2018 | $83,000 | +66.0% | 25,843 | +48.5% | 0.01% | +50.0% |
| Q2 2018 | $50,000 | +28.2% | 17,402 | +11.1% | 0.01% | -38.5% |
| Q3 2015 | $39,000 | -59.4% | 15,668 | -40.2% | 0.01% | -68.3% |
| Q1 2015 | $96,000 | – | 26,209 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |